MD Biosciences Releases: Histology Results Show Significant Arthritogenic Activity of ArthritoMab(TM) Antibody Cocktail in an 18-Day Model of Rheumatoid Arthritis

ZURICH, SWITZERLAND--(MARKET WIRE)--Jul 18, 2007 -- MD Biosciences releases histology results from an 18-day model of arthritis induced using the ArthritoMab(TM) cocktail of arthritogenic antibodies in Balb/c mice. Results show significant histological changes in the joint of the arthritis group as compared to the normal control group after just 18 days, providing researchers valuable data quickly compared to the traditional collagen-induced arthritis (CIA) model, which can take several weeks or more to produce similar histological results.

MORE ON THIS TOPIC